Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on April 6, 2026

Apr. 6, 2026

Nutrición Ayurveda: Escuela de Ayurveda de California ofrece Curso Online de Alimentación Ayurveda

Indeterminate EIN Presswire

Apr. 6, 2026

Longevity Medical Institute® Publishes Research on Intradiscal Stem Cell Therapy for Degenerative Disc Disease

Indeterminate EIN Presswire

Apr. 6, 2026

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

Indeterminate GlobeNewswire

Apr. 6, 2026

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

Indeterminate GlobeNewswire

Apr. 6, 2026

Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies

Indeterminate GlobeNewswire

Apr. 6, 2026

Avicanna Announces Changes to its Board of Directors

Indeterminate GlobeNewswire

Apr. 6, 2026

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Indeterminate GlobeNewswire

Apr. 6, 2026

Metabo Drops Claims Evaluated: Recent Investigation Into MetaboDrops Official Website Announcement

Indeterminate GlobeNewswire

Apr. 6, 2026

Overdoses Are Down, but Addiction Treatment Access Remains a Crisis

Indeterminate EIN Presswire

Apr. 6, 2026

Neuronetics Announces Chief Financial Officer Transition

Indeterminate GlobeNewswire

Apr. 6, 2026

Glyco Harmony Drops Claims Evaluated: Explore the Official Gluco Harmony Glycogen Support Website Facts

Indeterminate GlobeNewswire

Apr. 6, 2026

Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy

Indeterminate GlobeNewswire

Apr. 6, 2026

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

Indeterminate GlobeNewswire

Apr. 6, 2026

Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026

Indeterminate GlobeNewswire

Apr. 6, 2026

Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire

Apr. 6, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 6, 2026

Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States

Indeterminate GlobeNewswire

Apr. 6, 2026

Cytokinetics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire

Apr. 6, 2026

MISTR Founder Tristan Schukraft Joins the Producing Team of Titanique

Indeterminate GlobeNewswire

Apr. 6, 2026

GlucoZen Claim Evaluated: Highly-Effective Blood Sugar Support for Natural Glucose Harmony

Indeterminate GlobeNewswire